T
190.38
-3.75 (-1.93%)
| Previous Close | 194.13 |
| Open | 196.11 |
| Volume | 1,107,319 |
| Avg. Volume (3M) | 1,260,045 |
| Market Cap | 16,398,761,984 |
| Price / Earnings (TTM) | 9.90 |
| Price / Earnings (Forward) | 10.86 |
| Price / Sales | 0.750 |
| Price / Book | 3.32 |
| 52 Weeks Range | |
| Earnings Date | 21 Jul 2026 |
| Profit Margin | 7.18% |
| Operating Margin (TTM) | 16.16% |
| Diluted EPS (TTM) | 15.91 |
| Quarterly Revenue Growth (YOY) | 3.30% |
| Quarterly Earnings Growth (YOY) | 11.20% |
| Total Debt/Equity (MRQ) | 158.70% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | 2.46 B |
| Levered Free Cash Flow (TTM) | 899.88 M |
| Return on Assets (TTM) | 7.63% |
| Return on Equity (TTM) | 29.65% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Bullish |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | Tenet Healthcare Corporation | Bullish | Bullish |
AIStockmoo Score
2.5
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.0 |
| Average | 2.50 |
|
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Mid Core |
| % Held by Insiders | 0.73% |
| % Held by Institutions | 98.94% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 283.00 (Guggenheim, 48.65%) | Buy |
| Median | 267.50 (40.51%) | |
| Low | 264.00 (Leerink Partners, 38.67%) | Buy |
| Average | 270.50 (42.08%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 228.40 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Guggenheim | 12 Mar 2026 | 283.00 (48.65%) | Buy | 224.73 |
| Mizuho | 12 Mar 2026 | 265.00 (39.20%) | Buy | 224.73 |
| Leerink Partners | 20 Feb 2026 | 264.00 (38.67%) | Buy | 229.90 |
| Truist Securities | 17 Feb 2026 | 270.00 (41.82%) | Buy | 234.25 |
No data within this time range.
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 13 Mar 2000 | 06 Mar 2000 | 24 Mar 2000 | 0.01 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2000 | 0.010 | 1 | 0.01 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |